The store will not work correctly when cookies are disabled.
1-(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)prop-2-en-1-one
ID: ALA4744602
PubChem CID: 162647519
Max Phase: Preclinical
Molecular Formula: C20H20Cl2N2O
Molecular Weight: 375.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CC(=O)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C20H20Cl2N2O/c1-2-19(25)23-11-13-24(14-12-23)20(15-3-7-17(21)8-4-15)16-5-9-18(22)10-6-16/h2-10,20H,1,11-14H2
Standard InChI Key: RMEFUKDYHUBEOC-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.9522 -26.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5377 -25.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5377 -26.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9541 -24.6412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5402 -23.9266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7143 -23.9262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3040 -24.6462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7162 -25.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7136 -26.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3032 -27.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7137 -28.2114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5430 -28.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9537 -27.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3029 -23.2117 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.3042 -28.9229 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.7773 -26.0689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1878 -26.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1878 -25.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0128 -25.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4273 -26.0689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2523 -26.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0128 -26.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6628 -25.3539 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6628 -26.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4837 -26.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.30 | Molecular Weight (Monoisotopic): 374.0953 | AlogP: 4.41 | #Rotatable Bonds: 4 |
Polar Surface Area: 23.55 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.62 | CX LogP: 4.74 | CX LogD: 4.73 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.74 | Np Likeness Score: -0.82 |
References
1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142] [10.1016/j.bmcl.2020.127538] |